NMNAT2 and glaucoma: These findings imply that reduced NMNAT2 levels may play a role in neurodegeneration, while augmenting NMNAT2 and NAD levels could offer a promising therapeutic approach for the treatment of glaucoma and other axonal pathologies 117.